by NephJC Team
<p>Twice monthly (aspirational) recap of the NephJC journal club. NephJC reviews the most important manuscripts which are driving nephrology forward and improving our understanding of the kidney.</p>
Language
🇺🇲
Publishing Since
3/25/2019
Email Addresses
1 available
Phone Numbers
0 available
March 13, 2025
<p data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>The Filtrate</strong></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Joel Topf</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Jordy Cohen</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Nayan Arora</p><p data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>Special Guest </strong></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Katie Kwon <a href="https://bsky.app/profile/katiekwonmd.bsky.social">@katiekwonmd.bsky.social</a></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Mariana Murea <a href="https://x.com/MarianaMurea">@MarianaMurea</a></p><p data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>Editing by</strong></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Simon Topf and Joel Topf</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>Show Notes</strong></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">NephMadness at <a href="https://ajkdblog.org">AJKDblog.org</a></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><a href="https://ajkdblog.org/2025/03/01/nephmadness-2025-hemodialysis-region/">The Hemodialysis Region</a></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Vot<a href="https://www.tourneytopia.com/AJKD/NephMadness/SubmitPicks/Picks.aspx">e for your favorites</a></p>
February 26, 2025
<p data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>The Filtrate</strong></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Joel Topf</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Swapnil Hiremath</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">AC Gomez</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Sopia Ambruso</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Nayan Arora</p><p data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>Special Guests </strong></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><a href="https://med.umn.edu/bio/michelle-rheault">Michelle Rheault</a>, Director, Division of Pediatric Nephrology, Professor of Medicine</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><a href="https://www.arkanalabs.com/doctor/tiffany-caza/">Tiffany Caza</a>, Nephropathologist, Scientist and self-described Freely Filtered fan girl</p><p data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>Editing by</strong></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Simon Topf and Sophia Ambruso</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>Show Notes</strong></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">10. Healthcare Cyberattacks</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">9. ApoE in C3 glomerulonephropathy</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">8. Workforce woes in Adult and Pediatric Nephrology</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">7. Hyponatremia correction meta-analysis</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">6. Microvascular inflammation increases risk of graft loss - in all of its forms</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">5. Xenotransplantation</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">4. KDIGO CKD Guidelines</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">3. Hypertension control trials (ESPRIT, BPROAD)</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">2. The Renaissance of IgAN: IgAN treatment trials</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">1. FLOW: GLP-1 RAs in CKD</p><p data-rte-preserve-empty="true" style="white-space:pre-wrap;"><br></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"></p><p data-rte-preserve-empty="true" style="white-space:pre-wrap;"><br></p>
December 15, 2024
NephJC and guests discuss the RCT of finerenone in heart failure with preserved ejection fraction, unlocking new insights for treating this complex condition.
The Curbsiders Internal Medicine Podcast
Core IM Team
American College of Physicians
Channel Your Enthusiasm
The Curious Clinicians
CardioNerds
JAMA Network
The Clinical Problem Solvers
Mayo Clinic
Walker Redd, Emily Gutowski, Navin Kumar, Joyce Zhou, Blake Smith
AccessMedicine
NEJM Group
American Academy of Family Physicians
Medgeeks
JAMA Network
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.